South African medtech company AI Diagnostics has raised R85 million (about $4.6 million) in a pre-Series A funding round to accelerate deployment of its artificial intelligence-powered tuberculosis (TB) screening technology across Africa and other emerging markets. The funding will be used to expand clinical validation, strengthen regulatory approvals…
Read More
About The Author
